Blackstone Inc’s Terns Pharmaceuticals TERN Stock Holding History

Blackstone Inc’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-231,282	Closed	-$12.2M	–	670
2026 Q1	$12.2M	Sell	231,282 -245,472	-51%	-$10.1M	0.04%	77
2025 Q4	$19.3M	Buy	+476,754	New	+$11M	0.06%	78

Other funds holding TERN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Blackstone Inc's TERN Position: Q2 2026 in Review

Blackstone Inc sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 231,282 shares — an estimated $12.2M sold.

Blackstone Inc first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $19.3M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Blackstone Inc reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Blackstone Inc sold 231,282 Terns Pharmaceuticals shares in Q2 2026, an estimated $12.2M.
Blackstone Inc first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Blackstone Inc's Terns Pharmaceuticals position peaked at $19.3M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.